epigallocatechin gallate has been researched along with Renal Insufficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Fu, G; Jin, B; Meng, H; Pan, H; Shen, K; Wang, P; Wang, X; Wang, Y | 1 |
1 other study(ies) available for epigallocatechin gallate and Renal Insufficiency
| Article | Year |
|---|---|
Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Catechin; Cell Line; Cisplatin; Humans; Inflammation; Kidney; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Renal Insufficiency | 2015 |